While other cultivated meat companies are collapsing, this one turned a profit | E2317

Episode Summary

Executive Summary: A Tokyo episode of This Week in Startups explores cultivated meat through Dr. Yuki Hanyu’s company Integriculture. The discussion contrasts current cell-cultured meat limitations with a broader “cell agriculture” strategy that begins with profitable cosmetics and tools, then expands to food, leather, and medicine. The episode emphasizes open-source origins, regulation, branding, and the long timeline to mainstream adoption.

Main Topics: Japan as a startup and kaizen ecosystem (Priority: 4/5): Jason frames Tokyo as inspiring for founders because of its culture of pride, craftsmanship, and constant improvement. The episode is also used to promote Founder University in multiple regions. Why cultivated meat has not gone mainstream (Priority: 5/5): Hanyu explains that scaling, unit economics, and immature product quality have prevented cultured meat from reaching mass-market adoption, and that current products are still far from full imitation of real meat. Integriculture’s broader cell agriculture strategy (Priority: 5/5): Instead of positioning only as a cultured-meat company, Integriculture focuses on cell agriculture across cosmetics, food, leather, and biopharma, using revenue-generating products to fund the long-term vision. Open-source roots and commercialization (Priority: 4/5): The company grew out of a DIY/open-source cultured meat project, with manuals distributed publicly and a clear split between open-source education, nonprofit advocacy, and for-profit infrastructure. Regulation, culture, and market framing (Priority: 4/5): The conversation covers regulatory timing in Japan, bans and culture-war dynamics in the U.S., and the importance of framing products as niche or premium experiences before commodity markets. Product-market fit via cosmetics before food (Priority: 5/5): Hanyu says cosmetics provided early revenue, better supply-chain stability, and trust-based B2B relationships, helping the company survive while food products wait for regulation and scale.

Key Arguments: Cultivated meat has not gone mainstream primarily because scaling and unit economics are not yet solved, not because consumers have rejected the concept outright. Current cell-cultured meat often produces a slurry of cells rather than true muscle tissue, so it can approximate taste but not texture or structure. A company in this field should not focus only on cultured meat; broader cell agriculture creates multiple revenue paths and reduces dependence on one delayed market. Open-source communities can coexist with commercialization if roles are clearly separated: open-source for ideas, nonprofit for policy, for-profit for infrastructure. Cosmetics is a practical first market because it has existing demand, higher margins, and trust-based distribution channels that can support the company before food is ready. Regulatory acceptance and market adoption will likely happen in stages: stunt products, niche products, then mainstream commodities. The long-term opportunity extends beyond food to leather, cosmetics, and regenerative medicine, all of which can use similar cell-culture capabilities.

Data Points: Founder University cadence: Twice a year in Tokyo, twice a year in Riyadh, and twice a year in the United States - Jason describes the accelerator’s global program structure Open-source project start year: 2014 - Hanyu says the DIY cultured meat project began in 2014 Funding raised: $15M–$20M - Hanyu estimates total funds raised so far Profitability: Profitable last year - Hanyu says the company turned profitable through cosmetics Technical quality estimate: ~70% - Hanyu says current cultured meat is at about 70% of the way to full imitation, at best Scale target timeline: 10 years or more - Hanyu suggests commodity products like chicken could take about a decade or longer Current market share: 0.001% or less - Hanyu says cultivated meat is still tiny relative to the existing meat industry Regulatory timing in Japan: End of summer or beginning of autumn - Industry association view on when consumer affairs guidance may arrive Commercial product examples: Singapore approvals; quail meat; cultured foie gras - The conversation references products and approvals in the broader field

Pivotal Quotes: "It starts with some stunt products, then niche products, then something a bit more mainstream before going to the actual mainstream." — Dr. Yuki Hanyu: Explaining the commercialization path for cultivated meat "We are a cell agriculture company rather than cell cultured food or even cell cultured meat." — Dr. Yuki Hanyu: Defining Integriculture’s broader business model "The hard-earned sales channel is what matters, and it's not actually the patent on the ingredient itself." — Dr. Yuki Hanyu: Describing why trust and distribution matter more than IP in cosmetics

Implications: Cultivated meat may take years to reach commodity markets, so startups should build adjacent businesses, secure regulation, and use trust-heavy channels first. The winners may be companies that monetize tools and cosmetics before food goes mass-market.